Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001610717-24-000059 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-02-13 | 2024-02-09 | IDYA | Ruiz Briseno Andres | See Remarks | S - Sale | $46.02 | -2,000 | 24.5K | -8% | -$92.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-09 | S | D | 2,000 | $46.02 | 24,531 | D | — | — | (F2) This transaction was executed in multiple trades in prices ranging from $46.00 to $46.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |